From: Coexpression of VEGF-C and COX-2 and its association with lymphangiogenesis in human breast cancer
 | Significance Multivariate P (Cox regression) | 95%Confidence Interval | Hazard ratio |
---|---|---|---|
Disease-free survival | Â | Â | Â |
   LVD | 0.015* | 1.289–11.007 | 3.766 |
   ER | 0.045* | 0.134–0.976 | 0.361 |
   c-erbB-2 | 0.007* | 1.509–13.731 | 4.552 |
   LVI | 0.025* | 1.162–9.648 | 3.348 |
   VEGF-C expression | 0.167 |  |  |
   COX-2 expression | 0.330 |  |  |
Overall survival | Â | Â | Â |
   LVD | 0.002* | 2.021–20.595 | 6.452 |
   c-erbB-2 | 0.028* | 1.142–10.199 | 3.413 |
   VEGF-C expression | 0.155 |  |  |
   COX-2 expression | 0.375 |  |  |